Carcinoid Syndrome: The Combined Use of Ketanserin and Octreotide in the Management of an Acute Crisis during Anaesthesia

Roy R. , Carter R. , Wright P. Somatostatin, anaesthesia and the carcinoid syndrome. Anaesthesia 1987; 42: 627–632.

Thulin L. , Samnegard H. , Tyden G. , Long D. , Efendic S. Efficacy of somatostatin in a patient with carcinoid syndrome. Lancet 1978; 11: 43.

Bloom S.R. , Polak J.M. Somatostatin. Regular review. Br Med J 1987; 295: 288–295.

Lamberts S. , Koper J. , Reubi J.C. Editorial. Potential role of somatostatin analogues in the treatment of cancer. Eur J Clin Invest 1987; 17: 281–287.

Ahlman H. Serotonin and the carcinoid syndrome. In: Serotonin and the Cardiovascular System. Vanhoutte P. ed. Raven Press, New York 1985; 199–212.

Thandrogen F. , Saman S. , Opre L. Serotonin and the heart. Pharmacological evaluation with the S₂-serotonergic antagonist, ketanserin. In: Serotonin and the Cardiovascular System. Vanhoutte P. ed. Raven Press, New York 1985; 87–93.

Van Neuten J. , Janssens W. , Vanhoutte P. Serotonin and vascular smooth muscle. In: Serotonin and the Cardiovascular System. Vanhoutte P. ed. Raven Press, New York 1985; 95–103.

Gronstad K.O. , Nilsson O. , Dahlstrom A. , Skolnik G. , Ahlman H. Adrenergic control of serotonin release from carcinoid tumour cells in vitro and in vivo. J Surg Research 1987; 42: 141–146.

Gustafasen J. , Lendorf A. , Ruskov H. , Boesby S. Ketanserin versus placebo in carcinoid syndrome: controlled trial. Scand Gastroenterol 1986; 21: 816–818.

Casthely P. , Jabloons M. , Griepp R. , Ergin M. , Goodman K. Ketanserin in the preoperative and intraoperative management of a patient with carcinoid tumour undergoing tricuspid valve replacement. Anaesth Analg 1986; 65: 809–811.

Houghton K. , Caster J. Perioperative management of carcinoid syndrome using ketanserin. Anaesthesia 1986; 41: 596–599.

Cashman J. , Thompson M. , Bennett A. Influence of ketanserin pretreatment on the haemodynamic responses to sternotomy. Anaesthesia 1986; 41: 505–510.

Seibould J. , Jageneau A. Treatment of Raynaud's phenomenon with ketanserin: a selective antagonist of the serotonin₂ (5-HT₂) receptor. Arthrit Rheum 1984; 27: 2, 139–146.

Heykants J. , Van Peer A. , Woestenborghs R. , Gould S. , Mills J. Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration. Eur J Clin Pharmacol 1986; 31: 345–350.

Tournebrandt K. , Nobin A. , Ericssom M. , Thompson D. Circulation, respiration and serotonin levels in carcinoid patients during neurolept anaesthesia. Anaesthesia 1983; 38: 957–967.

Parry T. , Perera J. , Hammond J. Anaesthesia and gastric carcinoid. Anaesthesia 1986; 41: 1265–6.